作者:Li-Qiang Sun、Jie Chen、Ronald J. Mattson、James R. Epperson、Jeffrey A. Deskus、Wen-Sen Li、Katherine Takaki、Donald B. Hodges、Lawrence Iben、Cathy D. Mahle、Astrid Ortiz、David Molstad、Elaine Ryan、Krishnaswamy Yeleswaram、Cen Xu、Guanglin Luo
DOI:10.1016/j.bmcl.2003.09.030
日期:2003.12
A series of chiral heterocyclic aminopyrrolidine derivatives was synthesized as novel melatoninergic ligands. Binding affinity assays were performed on cloned human MT1 and MT2 receptors, stably expressed in NIH3T3 cells. Compound 16 was identified as an orally bioavailable agonist at MT1 and MT2 melatonin receptors with low vasoconstrictive activity. (C) 2003 Elsevier Ltd. All rights reserved.